The malaria hypothesis proposes a survival advantage for individuals with hemoglobin variants in areas of endemicPlasmodium falciparum malaria. Hemoglobin C (HbC) is a possible example in West Africa, where this hemoglobin has a centric distribution with high frequencies among certain populations including the Dogon ethnic group. To test whether HbC is associated with protection from malaria, we performed a case-control study in the Dogon of Bandiagara, Mali. HbC was present in 68 of 391 (17.4%) of uncomplicated malaria control cases, whereas it was detected in only 3 of 67 cases (4.5%) of severe malaria (odds ratio [OR], 0.22;P = .01). Further, HbC was present in only 1 of 34 cases (2.9%) with cerebral manifestations, the most common presentation of severe malaria in this population (OR, 0.14; P = .03). Episodes of uncomplicated malaria and parasitemias (4800-205 050/μL) were identified in cases of homozygous HbC (HbCC), which indicates thatP falciparum parasites are able to efficiently replicate within HbCC erythrocytes in vivo. These findings suggest that HbC does not protect against infection or uncomplicated malaria but can protect against severe malaria in the Dogon population of Bandiagara, Mali. The data also suggest that the protective effect associated with HbC may be greater than that of HbS in this population.

More than 50 years ago, Haldane1suggested that protection against malaria was conferred to individuals by a form of thalassemia. Since that time, the observed overlaps in the geographic distributions of malaria with hemoglobinopathies and other red blood cell disorders have been cited in support for the hypothesis that malaria has been an important evolutionary force in selection of these variants.2 Epidemiologic and in vitro support for the malaria hypothesis is best documented for the thalassemias3-5 and sickle hemoglobin (HbS),6-10 which in different regions of Africa, the Middle East, and Asia are maintained in a state of balanced polymorphism because of the protective effect of the heterozygous state against severe disease. Hemoglobin E (HbE) has also been associated with a reduced prevalence of severe Plasmodium falciparummalaria, with the odds of severe complications being 15%-20% of those found for homozygous hemoglobin A (HbA).11 

The malaria hypothesis has been invoked to explain the observed frequency of HbC in certain populations of West Africa, although epidemiological evidence has been contradictory.12-16 One study suggested an increased immunoglobulin response in individuals heterozygous for HbC.17 The presence of heterozygous HbC, however, was not found to correlate with reductions of P falciparum infections or parasite densities.12-14,17,18 Further, 2 clinical studies involving small numbers of HbC-trait individuals in some ethnic groups did not show significant evidence of reduced rates of severe disease.15,16 Although individuals homozygous for HbC (HbCC) were not observed in these studies, thereby leaving the possibility of protection from malaria by the HbCC state unresolved, these findings have not supported the possibility of a balanced polymorphism in which positive selection by malaria for HbC may counter negative selective pressures from the morbidity of the HbSC state,19 the occasional pathologic developments in the HbC homozygous state,20 and a possible reduced reproductive fitness of the βCgene.18,21 

The HbC and HbS mutations both occur in the 6th position in the β-globin amino acid sequence (β-6), where glutamic acid is substituted by lysine or valine, respectively. Although there are distinct pathologic consequences, the remarkable fact that both substitutions occur at β-6 may reflect a common influence of position on the effects of these different mutations in vivo. To test the hypothesis that HbC protects against severe malaria, we conducted an unmatched case-control study in the predominantly Dogon population of Bandiagara, Mali, where the gene frequency of HbC is high (0.087) and that of HbS is low (0.016).22,23 Here we report data that provide evidence for an association between HbC and protection against severe malaria in this Dogon population. The data also suggest less selection for the HbAS state in this group than for HbAC.

Background

Bandiagara, a village situated on a rocky plain above the Dogon escarpment in Mali, has a population of about 12 000 and mesoendemicP falciparum malaria with an intense seasonal occurrence from July to December. The present study was conducted during the malaria transmission seasons of 1997 and 1998 and was carried out in collaboration with local village leaders and traditional medical healers. Ethical approval for the study was obtained from the institutional review boards of the National Institute of Allergy and Infectious Diseases, Bethesda, MD; the University of Maryland, Baltimore, MD; and the University of Mali, Bamako, Mali. The patients were evaluated and enrolled at the Bandiagara Traditional Medicine Center.

Diagnosis and classification of cases

Inclusion and classification of each case were based on the symptoms, physical signs, and laboratory findings of malaria at the time of presentation. Severe malaria was established by microscopic confirmation of asexual P falciparum parasites in the peripheral blood and the following modification of established World Health Organization (WHO) criteria24: evidence for cerebral compromise (coma, obtundation, or witnessed convulsions without other explanation); severe anemia (hematocrit less than 15%); hyperparasitemia ofEp > 5 × 105/μL; hypoglycemia (serum glucose less than 2.2 mmol/L (40 mg/dL); and respiratory distress, clinical shock, or severe prostration, as detailed by Marsh et al.25 Uncomplicated malaria was established by microscopically confirmed parasitemia ofEp < 5 × 105/μL with fever, headache, myalgias, or gastrointestinal symptoms and without any findings of severe malaria. Splenomegaly in this study was defined as a Hackett score of at least 1.26 

Patients with uncomplicated malaria and parasitemia ofEp < 1 × 105/μL (control cases) were treated with chloroquine in an outpatient oral drug efficacy study (C. V. Plowe et al, unpublished data, 2000). Patients with severe malaria or parasitemia ofEp > 1 × 105/μL were placed under intensive care with treatment that included parenteral fluids, quinine, glucose, and antibiotics, as judged appropriate.

Hemoglobin typing

Hemoglobin types were determined by analysis of red blood cell lysates using cellulose acetate electrophoresis at an alkaline pH. Cellulose acetate plates (Helena Laboratories, Beaumont, TX) were stained with Ponceau red (Geimsa, St Louis, MO), yielding clear discrimination of hemoglobins A, F, S, and C/A2. Although HbC comigrates with HbA2 during electrophoresis, the presence of the HbC-trait was evident by its relative abundance in heterozygous and homozygous individuals. Homozygosity for HbC was also confirmed retrospectively for 1 of 7 cases from a frozen sample of preserved erythrocytes by citrate-agar electrophoresis (Helena Laboratories) and quantitative measurements of hemoglobins F, A2, and C by cation-exchange high-precision liquid chromatography (HPLC) using the variant β-thalassemia short program (Bio-Rad Laboratories, Hercules, CA). HbAS samples identified by electrophoresis were confirmed with metabisulfite sickling tests.

Statistical analysis

Demographic, clinical, and treatment profiles were recorded on case record forms, transferred to computer files, and analyzed by standard software including EpiInfo 6.0 (the Centers for Disease Control and Prevention, Atlanta, GA), Instat 2.03 (GraphPad Software, San Diego, CA), and Microsoft Excel (Microsoft, Seattle, WA). Parasitemias were log-transformed for statistical analysis. The controls for all comparisons were defined as uncomplicated malaria cases with parasitemia ofEp < 1 × 105/μL. We used the 2-tailed Fisher exact test, 2-tailed Student and Welch ttests, Mann-Whitney U (Wilcoxon rank sum) test, one-way analysis of variance (ANOVA), or Kruskal-Wallis nonparametric test as appropriate. Comparison statistics included the Mantel-Haenszel weighted odds ratio (OR), exact 95% confidence limit (CL), Mantel-Haenszel summary chi-square, and P values.P < .05 was considered statistically significant. Statistical power for comparisons was calculated using the observed OR and a 1-sided type I (α) error rate of 0.05.

During the 2 transmission seasons of 1997 and 1998, the study team evaluated 3645 patient presentations for symptoms of illness. Of these presentations, 789 cases fit the definition of uncomplicated malaria, and 89 cases met the criteria for severe malaria. The ethnic representation among all malaria cases was 63% Dogon, 13% Peulh, and 24% other ethnic groups including Bambara, Ouolof, and Sonrhai. Approximately equal percentages of the uncomplicated and severe malaria cases had a record of self-treatment with antimalarial remedies prior to presentation to the Medicine Center (44% and 48%, respectively, with this information available for 213 cases). Of the 789 uncomplicated malaria cases, 50% were male and 50% were female, whereas 55% of the 89 severe cases were male and 45% were female.

Among the 89 severe malaria cases, 67 occurred in the Dogon (Table1). The 22 cases in other ethnic groups were not of sufficient number to independently test for a significant association between HbC and a reduced prevalence of severe malaria, and these cases are not detailed in this report. As expected, patients with severe malaria were significantly younger and more anemic than controls with uncomplicated malaria. Of the 67 severe Dogon cases, 34 cases (51%) presented with cerebral manifestations, 12 (18%) with severe anemia, 18 (27%) with hyperparasitemia (Ep > 5 × 105/μL), 6 (9%) with respiratory distress or shock, and 6 (9%) with severe prostration. Different manifestations of severe malaria thus overlapped at presentation in 9 of the 67 cases. The severe malaria cases in the Dogon were more likely to be from rural areas surrounding Bandiagara than were the uncomplicated malaria control cases (28% vs 6%, respectively; P < .000 000 1) (Table 1). Complete residential information was not available for 16% of the study population.

Table 1.

Clinical and laboratory features of the Dogon malaria cases

Cases, no.Mean age, y (IQR)Mean hct,
% (IQR)
Mean parasitemia, ×103/μL (IQR)Splenomegaly, no. cases (%)Rural, no. cases (%)Urban, no. cases (%)
Total with uncomplicated malaria 488 8.1 (3-12) 33 (28-36) 57 (8-79) 93 (19) 30 (7) 390 (93) 
Ep < 1 × 105/μL (control cases) 391 9.1 (3-12) 33 (29-37) 26 (6-37) 70 (18) 19 (6) 315 (94) 
Ep > 1 × 105/μL 97 4.2* (2-5) 30* (26-34) 182 (118-216) 23 (24) 11 (13) 75 (87) 
Total with severe malaria 67 4.3 (1-4) 23 (17-29.5) 322 (51-558) 36 (54) 19 (28) 48 (72) 
 Cerebral manifestations 34 3.8 (2-4) 24 (19-29) 177 (50-229) 17 (50) 8 (23) 26 (77) 
 Severe anemia (hct<15%) 12 1.0 (1-2) 12 (11.8-13) 138 (10-124) 10 (83) 5 (45) 6 (55) 
 Hyperparasitemia (Ep>5×105/μL) 18 8.1 (3-6) 27 (23.8-30) 904 (641-1085) 5 (28) 3 (17) 15 (83) 
 Respiratory distress or shock 1.0 (0.3-1) 25 (21-28.8) 127 (72-203) 4 (66) 4 (67) 2 (33) 
 Severe prostration 1.5 (1-1.8) 29 (25.3-32) 100 (21-169) 2 (33) 4 (67) 2 (33) 
Cases, no.Mean age, y (IQR)Mean hct,
% (IQR)
Mean parasitemia, ×103/μL (IQR)Splenomegaly, no. cases (%)Rural, no. cases (%)Urban, no. cases (%)
Total with uncomplicated malaria 488 8.1 (3-12) 33 (28-36) 57 (8-79) 93 (19) 30 (7) 390 (93) 
Ep < 1 × 105/μL (control cases) 391 9.1 (3-12) 33 (29-37) 26 (6-37) 70 (18) 19 (6) 315 (94) 
Ep > 1 × 105/μL 97 4.2* (2-5) 30* (26-34) 182 (118-216) 23 (24) 11 (13) 75 (87) 
Total with severe malaria 67 4.3 (1-4) 23 (17-29.5) 322 (51-558) 36 (54) 19 (28) 48 (72) 
 Cerebral manifestations 34 3.8 (2-4) 24 (19-29) 177 (50-229) 17 (50) 8 (23) 26 (77) 
 Severe anemia (hct<15%) 12 1.0 (1-2) 12 (11.8-13) 138 (10-124) 10 (83) 5 (45) 6 (55) 
 Hyperparasitemia (Ep>5×105/μL) 18 8.1 (3-6) 27 (23.8-30) 904 (641-1085) 5 (28) 3 (17) 15 (83) 
 Respiratory distress or shock 1.0 (0.3-1) 25 (21-28.8) 127 (72-203) 4 (66) 4 (67) 2 (33) 
 Severe prostration 1.5 (1-1.8) 29 (25.3-32) 100 (21-169) 2 (33) 4 (67) 2 (33) 

The mean age, hematocrit, and parasitemia are listed with interquartile ranges (IQRs) in parentheses. The number of rural and urban cases for which residential information was available are listed. Hct indicates hematocrit.

*

Significant difference in age and hematocrit between uncomplicatedEP>1×105/μL cases and control cases (P<.001 by the Mann-Whitney U test andP<.001 by the Student t test, respectively).

Significant difference in age and hematocrit between severe cases and control cases (P<.001 by the Student t test andP<.001 by the Welch t test, respectively).

Significant difference between rural proportion of severe cases and rural proportion of uncomplicated control cases (28% vs 6%;P<.0000001 by the chi-square test, with 1 degree of freedom).

As a baseline for analysis of hemoglobin type prevalences in this study, we first compared the distribution of hemoglobin types in the Dogon cases of uncomplicated malaria with those reported from an extensive survey of hemoglobinopathies in the Dogon country.22,23 The results of this comparison showed that the reported prevalences of HbAA, HbAC, HbCC, and HbAS were indistinguishable from the prevalences of 80.0% HbAA, 15.9% HbAC, 1.5% HbCC, and 2.6% HbAS found in the Dogon cases of uncomplicated malaria (chi-square test with 3 degrees of freedom,P = .95) (Table 2). Estimated gene frequencies from the above observations in the uncomplicated malaria controls (βA = 0.892,βC = 0.095, andβS = 0.013) and in the overall study population among the Dogon (βA = 0.901,βC = 0.084, andβS = 0.015) were calculated to be consistent with frequencies of the Hardy-Weinberg equilibrium27(chi-square test with 5 degrees of freedom, P = .80 for controls; chi-square test with 5 degrees of freedom,P = .61 for all Dogon cases).

Table 2.

Distribution of hemoglobin types in uncomplicated malaria control cases among the Dogon

Cases, No.Hemoglobin type, %
AAACCCASSC
Reported22,23  3473 80.8 14.9 1.09 3.0 0.3 
Observed 391 80.0 15.9 1.5 2.6 
Cases, No.Hemoglobin type, %
AAACCCASSC
Reported22,23  3473 80.8 14.9 1.09 3.0 0.3 
Observed 391 80.0 15.9 1.5 2.6 

Observed distributions are from uncomplicated malaria control cases with parasitemia <1×105/μL (Table 1).

Table 3 presents the distribution of hemoglobin types among the severe and uncomplicated cases of malaria in the Dogon. The percentage of cases with HbC (ie, HbAC and HbCC) in cases of severe malaria (4.5%) was significantly lower than the percentage in uncomplicated control cases (17.4% = 15.9% + 1.5%; OR, 0.22; 95% CL, 0.04-0.74;P = .01). The 7 homozygous HbCC cases all presented with uncomplicated malaria.

Table 3.

Distribution by hemoglobin type in cases of uncomplicated and severe malaria

Hemoglobin type, No. cases (%)
AAACCCAS
Total with uncomplicated malaria 392 (80.3) 76 (15.6) 7 (1.4) 13 (2.7) 
Ep < 1 × 105/μL (control cases) 313 (80.1) 62 (15.9) 6 (1.5) 10 (2.6) 
Ep > 1 × 105/μL 79 (81.4) 14 (14.4) 1 (1.0) 3 (3.1) 
Total with severe malaria 61 (91.0) 3 (4.5)3-150 3 (4.5)  
 Cerebral manifestations 31 (91.2) 1 (2.9)3-151 2 (5.9) 
 Severe anemia (hct<15%) 12 (100) 
 Hyperparasitemia (Ep>5×105/μL) 15 (83.3) 1 (5.6) 2 (11.1) 
 Respiratory distress or shock 4 (66.7) 1 (16.7) 1 (16.7)  
 Severe prostration 6 (100) 
Hemoglobin type, No. cases (%)
AAACCCAS
Total with uncomplicated malaria 392 (80.3) 76 (15.6) 7 (1.4) 13 (2.7) 
Ep < 1 × 105/μL (control cases) 313 (80.1) 62 (15.9) 6 (1.5) 10 (2.6) 
Ep > 1 × 105/μL 79 (81.4) 14 (14.4) 1 (1.0) 3 (3.1) 
Total with severe malaria 61 (91.0) 3 (4.5)3-150 3 (4.5)  
 Cerebral manifestations 31 (91.2) 1 (2.9)3-151 2 (5.9) 
 Severe anemia (hct<15%) 12 (100) 
 Hyperparasitemia (Ep>5×105/μL) 15 (83.3) 1 (5.6) 2 (11.1) 
 Respiratory distress or shock 4 (66.7) 1 (16.7) 1 (16.7)  
 Severe prostration 6 (100) 
F3-150

The hemoglobin type is significantly less frequent in severe cases compared with uncomplicated control cases. The OR of 0.22 (exact 95% CL, 0.04-0.74; Mantel-Haenszel summary chi-square test, P = .01) was calculated using the total of AC and CC versus the total of AA and AS hemoglobin types after stratification by age (0-2 years, 3-6 years, 7-15 years, or more than 16 years).

F3-151

Hemoglobin type is significantly less frequent in cases with cerebral manifestations compared to uncomplicated control cases (Fisher exact test, P=.03).

The prevalence of HbAS was not found to be significantly different in the Dogon groups with severe and uncomplicated malaria (OR, 1.91; 95% CL, 0.31-8.92; P = .59) (Table 3). Cerebral manifestations were identified in 2 of the 3 severe malaria HbAS cases.

Comparisons of mean parasitemia by hemoglobin type relative to HbAA among the Dogon population are presented in Table4. Among the uncomplicated malaria control cases, uncomplicated cases withEp > 1 × 105/μL, or severe malaria cases, there was no significant difference in mean parasitemia between the HbAC or HbAS cases and the HbAA cases.

Table 4.

Comparison of mean parasitemias by hemoglobin type among the Dogon

Hemoglobin type, No. cases (%)P
AAACCCAS
Total with uncomplicated malaria      
Ep < 1 × 105/μL (control cases) 313 (80.0) 62 (15.9) 6 (1.5) 10 (2.6)  
  Mean log10Ep(IQR) 4.11 (3.73-4.56) 4.17 (3.91-4.58) 4.22 (3.85-4.51) 4.05 (3.68-4.56) .87 
Ep > 1 × 105/μL 79 (81.4) 14 (14.4) 1 (1.0) 3 (3.1)  
  Mean log10Ep(IQR) 5.22 (5.06-5.34) 5.22 (5.09-5.25) 5.31 5.29 (5.16-5.38) .784-150 
Total with severe malaria 61 (91.0) 3 (3.1) 0 (0) 3 (3.1)  
  Mean log10Ep(IQR) 5.03 (4.71-5.59) 4.99 (4.43-5.58)  5.11 (4.75-5.77) .964-150 
Hemoglobin type, No. cases (%)P
AAACCCAS
Total with uncomplicated malaria      
Ep < 1 × 105/μL (control cases) 313 (80.0) 62 (15.9) 6 (1.5) 10 (2.6)  
  Mean log10Ep(IQR) 4.11 (3.73-4.56) 4.17 (3.91-4.58) 4.22 (3.85-4.51) 4.05 (3.68-4.56) .87 
Ep > 1 × 105/μL 79 (81.4) 14 (14.4) 1 (1.0) 3 (3.1)  
  Mean log10Ep(IQR) 5.22 (5.06-5.34) 5.22 (5.09-5.25) 5.31 5.29 (5.16-5.38) .784-150 
Total with severe malaria 61 (91.0) 3 (3.1) 0 (0) 3 (3.1)  
  Mean log10Ep(IQR) 5.03 (4.71-5.59) 4.99 (4.43-5.58)  5.11 (4.75-5.77) .964-150 

The P values were determined from comparisons of log10Ep distributions in the different hemoglobin groups using a one-way analysis of variance (ANOVA). The overall comparison of log10Ep distributions for all study participants by hemoglobin type did not show significant differences (P=.86). The mean log10 indicates the mean of individual log transformed parasitemia counts.

F4-150

Determined using the Kruskal-Wallis ANOVA test.

Table 5 presents the results of the calculated ORs and P values for the prevalences of HbC and HbS in the severe malaria syndromes among the Dogon cases listed in Table 3. In this analysis, the total prevalence of HbC (HbAC plus HbCC presentations) was found to be significantly reduced in the cerebral manifestations group (OR, 0.14; 95% CL, 0.00-0.89;P = .03). The numbers of cases were not sufficient to determine whether the prevalence of HbC differed significantly in severe anemia, hyperparasitemia, respiratory distress or shock, or severe prostration.

Table 5.

ORs from the prevalences of hemoglobins C and S in severe malaria syndromes among the Dogon

Severe malaria syndromeAC or CCAS
Cerebral manifestations   
 OR (CL) 0.14 (0-0.89) 2.38 (0.24-11.87) 
P .03 .25  
Severe anemia (hct<15%)   
 OR (CL) 0.00 (0-1.76) 0.00 (0-16.09) 
P .23 1  
Hyperparasitemia (Ep>5×105/μL)   
 OR (CL) 0.28 (0.01-1.85) 4.76 (0.47-25.09) 
P .33 .09  
Respiratory distress or shock   
 OR (CL) 0.95 (0.02-8.69) 7.62 (0.15-77.18) 
P .16  
Severe postration   
 OR (CL) 0.00 (0-4.13) 0.00 (0-36.78) 
P .59 
Severe malaria syndromeAC or CCAS
Cerebral manifestations   
 OR (CL) 0.14 (0-0.89) 2.38 (0.24-11.87) 
P .03 .25  
Severe anemia (hct<15%)   
 OR (CL) 0.00 (0-1.76) 0.00 (0-16.09) 
P .23 1  
Hyperparasitemia (Ep>5×105/μL)   
 OR (CL) 0.28 (0.01-1.85) 4.76 (0.47-25.09) 
P .33 .09  
Respiratory distress or shock   
 OR (CL) 0.95 (0.02-8.69) 7.62 (0.15-77.18) 
P .16  
Severe postration   
 OR (CL) 0.00 (0-4.13) 0.00 (0-36.78) 
P .59 

The OR for the AC and CC hemoglobin types, or for the AS hemoglobin type, among severe cases and uncomplicated controls were determined using the chi-square or Fisher exact tests (2×2 tables). Comparisons were not stratified by age. The CL is exact 95%.

The Dogon presenting for this study showed a somewhat higher prevalence of severe malaria than the Peulh and other ethnic groups (data not shown). Residence data indicated a possible catchment effect because the proportion of Dogon severe cases from rural areas (28%) was significantly higher than the proportion of uncomplicated control cases from rural areas (6%; P < .000 000 1) (Table 1). To reduce a possible bias resulting from the selective referral of very ill children from remote, predominately Dogon villages outside Bandiagara, we compared the hemoglobin prevalences in urban severe malaria cases against those in randomly matched urban uncomplicated malaria control cases. Although this smaller sample size reduced the statistical power for this comparison from 73% (type II error of 0.27) (Table 3) to 53% (type II error of 0.47), the results remained consistent with protection against severe malaria by HbC (OR, 0.22; 95% CL, 0.02-1.00; P = .06) (Table6).

Table 6.

Age-matched comparison of severe malaria among urban Dogon cases

Severe cases, No.Control cases, No.OR (CL)P
Hemoglobin type     
 AA 44 76   
 AC or CC 16 0.22 (0.02-1.00) .06 
 AS 1.00 (0.09-7.36) .66  
Clinical features     
 Total cases 48 96   
 Mean age, y (IQR) 5.0 (2-4) 5.0 (2-5)   
 Urban residence,
No. cases (%) 
48 (100) 96 (100)   
 Cerebral manifestations 26   
 Severe anemia (hct<15%)   
 Hyperparasitemia (Ep>5×105/μL) 15   
 Respiratory distress
or shock 
  
 Severe prostration   
Severe cases, No.Control cases, No.OR (CL)P
Hemoglobin type     
 AA 44 76   
 AC or CC 16 0.22 (0.02-1.00) .06 
 AS 1.00 (0.09-7.36) .66  
Clinical features     
 Total cases 48 96   
 Mean age, y (IQR) 5.0 (2-4) 5.0 (2-5)   
 Urban residence,
No. cases (%) 
48 (100) 96 (100)   
 Cerebral manifestations 26   
 Severe anemia (hct<15%)   
 Hyperparasitemia (Ep>5×105/μL) 15   
 Respiratory distress
or shock 
  
 Severe prostration   

Each urban case of severe malaria among the Dogon ethnic group was randomly matched with two uncomplicated malaria control cases from within Bandiagara, Mali, that were in the same ethnic group and age group (0-2 years, 3-6 years, 7-15 years, or more than 16 years). The Mantel-Haenszel weighted summary OR with exact 95% CL are from comparison of the AC and CC versus AA and AS hemoglobin types, or of the AS versus non-AS hemoglobin types, between cases and controls after stratification by age.

We also analyzed the prevalence of splenomegaly in uncomplicated malaria controls and severe malaria cases by hemoglobin type (Table7). Splenomegaly was found to be significantly more frequent in cases of severe malaria in the Dogon (P < .001) (Table 7). No instances of splenomegaly were detected in the 7 CC cases presenting in this study.

Table 7.

Prevalence of splenomegaly by hemoglobin type among the Dogon cases

Hemoglobin type, No. cases (%)Total, No. cases (%)
AAACCCAS
Uncomplicated malaria controls 66 (21) 11 (18) 0 (0) 3 (30) 70 (18) 
Severe malaria 32 (52) 2 (66) 0 (0) 2 (66) 36 (54) 
Hemoglobin type, No. cases (%)Total, No. cases (%)
AAACCCAS
Uncomplicated malaria controls 66 (21) 11 (18) 0 (0) 3 (30) 70 (18) 
Severe malaria 32 (52) 2 (66) 0 (0) 2 (66) 36 (54) 

In uncomplicated malaria control cases, 313 HbAA, 62 HbAC, 6 HbCC, and 10 HbAS cases were examined for splenomegaly. In the severe malaria cases, 61 HbAA, 3 HbAC, 0 HbCC, and 3 HbAS cases were examined for splenomegaly. The prevalence of splenomegaly was significantly more frequent in patients with severe malaria than in uncomplicated malaria controls (chi-square test, P<.001; OR 2.73; 95% CL, 1.54-5.31).

The results of this study indicate that HbC is associated with protection against the severe form of P falciparum malaria in the Dogon of Bandiagara, Mali. In this ethnic group, the prevalence of HbC was significantly lower among cases of severe malaria than among cases of uncomplicated malaria. The protective effect indicated by the calculated OR of 0.22 would correspond roughly to an 80% reduction in the risk of severe malaria. As 16% of the Dogon population in Bandiagara carry at least 1 βC allele, the protective potential of this association (approximately 13% potential severe cases prevented28) would suggest an effect in the Dogon that is comparable to that associated with HbS in other populations.8 

HbCC individuals with P falciparum infections were readily found, including 1 case withEp = 205 050/μL, a parasitemia that corresponds to approximately 5% infected erythrocytes in the bloodstream. These findings show that P falciparum can infect and proliferate within the bloodstream of the HbCC homozygote even though P falciparum parasites have been reported not to proliferate in HbCC erythrocytes under in vitro conditions.29,30 None of the 7 HbCC cases manifested severe or life-threatening complications of malaria.

This study was not designed to determine whether HbC was associated with a protection against uncomplicated malaria. However, the fact that the prevalence of HbC in the malaria control group is similar to that observed in the Dogon community does suggest lack of a major effect from HbC on parasite infection and uncomplicated malaria. Prevalences of 15.9% HbAC and 1.5% HbCC in the uncomplicated malaria control cases compare closely to reported average rates of 14.9% HbAC and 1.1% HbCC in the Dogon population.22,23 These findings further suggest a parallel between HbC in the Dogon and HbS in other ethnic groups, which in the heterozygous state protects not so much against the occurrence of P falciparum infection and uncomplicated malaria as against the severe forms of the disease.8 In the cases of uncomplicated malaria among the Dogon, mean parasitemias among the HbAC, HbCC, or HbAS hemoglobin types did not significantly differ relative to the HbAA type (Table 4), which is consistent with previous studies.12-14,17,18 

The relatively high proportion of Dogon cases presenting with severe malaria in this study may reflect selection bias from a catchment effect and may thus indicate a limitation in the study design with regard to residential criteria for enrollment.31 Separate analysis of this catchment effect and incorporation of 2 matched uncomplicated controls for each urban severe malaria case confirmed the OR for a protective effect of HbC against severe malaria. Although this strategy was used to minimize possible confounding variables, we recognize that differences in such factors as the prevalence of the HbC trait, entomologic inoculation rates, or self-treatment with antimalarial remedies could have affected prevalences of severe malaria in this analysis.

Severe anemia was found to be relatively infrequent in our study, so the number of cases was insufficient to test whether the HbC trait is associated with protection against this manifestation of severe malaria. In contrast to reports from other regions of Africa, where severe anemia (defined as a hemoglobin of less than 50 g/L [5 g/dL]) was present in 30%-80% of severe malaria cases,8,32,33 only 18% of the severe cases in Bandiagara presented with a comparable degree of anemia. Possible roles of other genetic loci affecting malaria susceptibility, parasite transmission intensity, prior antimalarial treatment, nutritional differences, and other factors in anemia have yet to be explored. In The Gambia in West Africa, we note that a reduced prevalence of anemia but not of cerebral malaria was linked to the human leukocyte antigen (HLA)-DRB1*1302 haplotype, and the HLA-B53 allele was associated with protection from both forms of the severe disease.8 

Of the 16 HbAS Dogon cases in the study, 3 cases presented with manifestations of severe malaria, and 2 of these cases presented with convulsions. While additional studies will be required to establish the risk of severe malaria in Dogon children with HbAS, these cases raise the question whether there is a less relative selection for HbAS by malaria in Dogons than for HbAC and HbCC. Such a possibility would be consistent with the fact that incidences of HbS and HbC are 3% and 16%, respectively, in the Dogons, which is different from the respective incidences of 20% HbS and 3% HbC in the Malinke group34 from which the Dogons are thought to have migrated 500-800 years ago.35 Genetic differences between these populations or regional environment factors affecting protection by HbS or HbC may account for the contrast in the current findings from our previous study of a predominantly Bambara study group in Bamako, Mali,15 and those from another large study in The Gambia.8 Linkage disequilibrium in these different populations may also be present between theβS orβC genes and other loci that affect susceptibility to severe malaria.

The possibility that protective effects associated with different hemoglobin mutations may vary among different human populations is consistent with other reported findings. Early or vigorous development of malaria immunity has been associated with protection of sickle cell trait and thalassemia,36-40 and ethnic variations in the immunological response to P falciparum infection and rates of the clinical episodes of malaria are described from clinical studies in West Africa.41,42 Differences in the prevalence of splenomegaly from malaria infection have been found among West African populations.43,44 Specific environmental influences and diets (eg, the effect of fava beans in the case of HbE)45may also contribute to the selection of hemoglobin variants. Investigations of questions raised by these observations should provide fundamental information on factors that affect the distribution of hemoglobinopathies and determine the disease manifestations of severe malaria.

We thank the residents of Bandiagara, Mali; the Bandiagara Traditional Healers group; Dr Chiaka Diakite and the staff of the Traditional Medical Center in Bandiagara for their help and encouragement; Boureima Ouologuem and Akouni Dougnon for their assistance; the Regional Malaria Control Program at Mopti, Mali; and Robert W. Gwadz and Richard K. Sakai for their efforts in the support of this work.

Supported in part by the US Agency for International Development (USAID) through the Health and Human Resources Analysis for Africa (HHRAA) Program and through the USAID Mission, Bamako, Mali.

The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 U.S.C. section 1734.

1
Haldane
JBS
The rate of mutation of human genes.
Hereditas.
35(suppl)
1949
267
273
2
Flint
J
Harding
RM
Boyce
AJ
Clegg
JB
The population genetics of the haemoglobinopathies.
Baillieres Clin Haematol.
11
1998
1
51
3
Siniscalo
M
Bernini
L
Filippi
G
et al
Population genetics of hemoglobin variants, thalassemia and glucose-6-phosphate dehydrogenase deficiency, with particular reference to the malaria hypothesis.
Bull World Health Organ.
34
1966
379
393
4
Flint
J
Hill
AVS
Bowden
DK
et al
High frequencies of α-thalassaemia are the result of natural selection by malaria.
Nature.
321
1986
744
750
5
Clegg
JB
Weatherall
DJ
Thalassemia and malaria: new insights into an old problem.
Proc Assoc Am Physicians.
111
1999
278
282
6
Fleming
AF
Storey
J
Molineaux
L
Iroko
EA
Attai
EDE
Abnormal haemoglobins in the Sudan savanna of Nigeria, I: prevalence of haemoglobins and relationship between sickle cell trait, malaria, and survival.
Ann Trop Med Parasitol.
73
1979
161
172
7
Allison
AC
Polymorphism and natural selection in human populations.
Cold Spring Harb Symp Quant Biol.
29
1964
137
149
8
Hill
AVS
Allsopp
CE
Kwiatkowski
D
et al
Common West African HLA antigens are associated with protection from severe malaria.
Nature.
352
1991
595
600
9
Pasvol
G
Weatherall
DJ
Wilson
RJM
Cellular mechanism for the protective effect of haemoglobin S against P falciparum malaria.
Nature.
274
1978
701
703
10
Friedman
MJ
Erythrocytic mechanism of sickle cell resistance to malaria.
Proc Natl Acad Sci U S A.
75
1978
1994
1997
11
Hutagalung
R
Wilairatana
P
Looareesuwan
S
Brittenham
GM
Aikawa
M
Gordeuk
VR
Influence of hemoglobin E trait on the severity of falciparum malaria.
J Infect Dis.
179
1999
283
286
12
Thompson
GR
Significance of haemoglobins S and C in Ghana.
Br Med J.
1
1962
682
685
13
Thompson
GR
Malaria and stress in relation to hemoglobin S and C.
Br Med J.
2
1963
976
978
14
Ringelhann
B
Hathorn
MKS
Jilly
P
Grant
F
Parniczky
G
A new look at the protection of Hemoglobin AS and AC genotypes against Plasmodium falciparum infection: a census tract approach.
Am J Hum Genet.
28
1976
270
279
15
Guinet
F
Diallo
DA
Minta
D
et al
A comparison of the incidence of severe malaria in Malian children with normal and C-trait hemoglobin profiles.
Acta Trop.
68
1997
175
182
16
Gilles
HM
Fletcher
KA
Hendrickse
RG
Lindner
R
Reddy
S
Allan
N
Glucose-6-phosphate-dehydrogenase deficiency, sickling, and malaria in African children in south western Nigeria.
Lancet.
1
1967
138
140
17
Storey
J
Fleming
AF
Cornille-Brogger
R
Molineaux
L
Matsushima
T
Kagan
I
Abnormal haemoglobins in the Sudan savanna of Nigeria, IV: malaria, immunoglobulins and antimalarial antibodies in haemoglobin AC individuals.
Ann Trop Med Parasitol.
73
1979
311
315
18
Labie
D
Richin
C
Pagnier
J
Gentilini
M
Nagel
RL
Hemoglobins S and C in Upper Volta.
Hum Genet.
65
1984
300
302
19
Gill
FM
Sleeper
LA
Weiner
SJ
et al
Clinical events in the first decade in a cohort of infants with sickle cell disease.
Blood.
86
1995
776
783
20
Smith
EW
Krevans
JR
Clinical manifestations of hemoglobin C disorders.
Bull Johns Hopkins Hosp.
104
1959
17
43
21
Devoucoux
R
Hurpin
C
Baudon
D
et al
Population genetics of abnormal hemoglobins in Burkina Faso, West Africa.
Ann Hum Biol.
18
1991
295
302
22
Diallo
D
Traore
AK
Baby
M
Rhaly
AAG
Bellis
G
Chaventre
A
Haemoglobinopathies C and S in the Dogons.
Nouv Rev Fr Hematol.
35
1993
551
554
23
Ducrocq
R
Bennani
M
Bellis
G
et al
Hemoglobinopathies in the Dogon country: presence of beta S, beta C, and delta A′ genes.
Am J Hematol.
46
1994
245
247
24
World Health Organization, Division of Control of Tropical Diseases. Severe and complicated malaria
Warrell DA, Molyneux ME, and Beales PF, eds.
Trans R Soc Trop Med Hyg.
84(suppl 2)
1990
1
65
25
Marsh
K
Forster
D
Waruiru
C
et al
Indicators of life-threatening malaria in African children.
N Engl J Med.
332
1995
1399
1404
26
Hackett
LW
Spleen measurement in malaria.
J Natl Malaria Soc.
3
1944
121
133
27
Bodmer
WF
Cavalli-Sforza
LL
Genes in populations.
Genetics, Evolution, and Man.
Bodmer
WF
Cavalli-Sforza
LL
1976
231
258
Freeman
San Francisco, CA
28
Miettinen
OS
Proportion of disease caused or prevented by a given exposure, trait or intervention.
Am J Epidemiol.
99
1974
325
332
29
Friedman
MJ
Roth
EF
Nagel
RL
Trager
W
The role of hemoglobins C, S, and Nbalt in the inhibition of malaria parasite development in vitro.
Am J Trop Med Hyg.
28
1979
777
780
30
Olson
JA
Nagel
RL
Synchronized cultures of P falciparum in abnormal red cells: the mechanism of the inhibition of growth in Hb CC cells.
Blood.
67
1986
997
1001
31
Hayes
RJ
Marsh
K
Snow
RW
Case-control studies of severe malaria.
J Trop Med Hyg.
95
1992
157
166
32
Slutsker
L
Taylor
TE
Wirima
JJ
Steketee
RW
In-hospital morbidity and mortality due to malaria-associated severe anaemia in two areas of Malawi with different patterns of malaria infection.
Trans R Soc Trop Med Hyg.
88
1994
548
551
33
Snow
RW
Bastos de Azevedo
I
Lowe
BS
et al
Severe childhood malaria in two areas of markedly different falciparum transmission in East Africa.
Acta Trop.
57
1994
289
300
34
Ecole Nationale de Medecine et de Pharmacie du Mali
Evaluation sanitaire des cercles de Kenieba, Bafoulabe et Kita: Sanitary Development Project.
1981
220
221
World Bank
35
Beaudain
G
Les Dogons du Mali.
1984
Armand Colin
Paris
36
Marsh
K
Otoo
L
Hayes
RJ
Carson
DC
Greenwood
BM
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection.
Trans R Soc Trop Med Hyg.
83
1989
293
303
37
Bayoumi
RA
Abu-Zeid
YA
Abdoulhadi
NH
et al
Cell-mediated immune responses to Plasmodium falciparum purified soluble antigens in sickle-cell trait subjects.
Immunol Lett.
25
1990
243
249
38
Abu-Zeid
YA
Abdoulhadi
NH
Hviid
L
et al
Lymphoproliferative responses to Plasmodium falciparum antigens in children with and without the sickle cell trait.
Scand J Immunol.
34
1991
237
242
39
Le Hesran
JY
Personne
I
Personne
P
et al
Longitudinal study of Plasmodium falciparum infection and immune responses in infants with or without the sickle cell trait.
Int J Epidemiol.
28
1999
793
798
40
Williams
TN
Maitland
K
Bennett
S
et al
High incidence of malaria in α-thalassemic children.
Nature.
383
1996
522
525
41
Modiano
D
Petrarca
V
Sirima
BS
et al
Different response to Plasmodium falciparum malaria in West African sympatric groups.
Proc Natl Acad Sci U S A.
93
1996
13206
13211
42
Modiano
D
Chiucchiuini
A
Petrarca
V
et al
Interethnic differences in the humoral response to non-repetitive regions of the Plasmodium falciparum circumsporozoite protein.
Am J Trop Med Hyg.
61
1999
663
667
43
Oomen
JMV
Meuwissen
JHE
Gemert
W
Differences in blood status of three ethnic groups inhabiting the same locality in northern Nigeria: anaemia, splenomegaly and associated causes.
Trop Geogr Med.
31
1979
587
606
44
Greenwood
BM
Groenendaal
F
Bradley
AK
Greenwood
AM
Shenton
F
Tulloch
S
Ethnic differences in the prevalence of splenomegaly and malaria in the Gambia.
Ann Trop Med Parasitol.
81
1987
345
354
45
Kitayaporn
D
Nelson
KE
Charoenlarp
P
Pholpothi
T
Hemoglobin-E in the presence of oxidative substances from fava bean may be protective against Plasmodium falciparum malaria.
Trans R Soc Trop Med Hyg.
86
1992
240
244

Author notes

Thomas E. Wellems, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bldg 4, Rm 126, 4 Center Dr, MSC 0425, Bethesda, MD 20892-0425; e-mail:tew@helix.nih.gov.

Sign in via your Institution